Egypt Intrauterine Contraceptive Devices Market Size & Outlook, 2025-2033

Egypt Intrauterine Contraceptive Devices Market Insights

As per Reed Intelligence insights, the Egypt Intrauterine Contraceptive Devices Market stood at USD 24.86 Million in 2024 and is anticipated to grow to USD 33.05 Million by 2033.
The Egypt market is expected to advance at a CAGR of 3.23% from 2025 through 2033.
In 2024, Hormonal Intrauterine Devices accounted for the highest share of the By Type market size.
During the forecast period, Copper Intrauterine Devices is set to register the highest growth, making it the most lucrative By Type segment.

Other Key Findings

In 2024, Egypt accounted for 0.8% of the global Intrauterine Contraceptive Devices Market size.
By 2033, United States is expected to lead the global Intrauterine Contraceptive Devices Market in terms of market size.
Within Middle East and Africa, United Arab Emirates is projected to dominate the regional Intrauterine Contraceptive Devices Market size by 2033.
United Arab Emirates is identified as the fastest-growing market in Middle East and Africa, anticipated to reach USD 170.64 Million by 2033.

Report Summary

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 24.86 Million
Market Size In 2033	USD 33.05 Million
Largest segment	Hormonal Intrauterine Devices
Units	Revenue in USD Million
CAGR	3.23% (2025-2033)
Segmnetation Covered
By Type	Hormonal Intrauterine Devices Copper Intrauterine Devices
By Product	Mirena Skyla Paragard Essure Levosert Others
By End-User	Hospitals Gynecology Clinics Community Healthcare Centers
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Egypt Intrauterine Contraceptive Devices Market By Type 2025-2033 (USD Million)

By Type	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Hormonal Intrauterine Devices	XX.x	XX.x	XX.x	15.96	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Copper Intrauterine Devices	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Egypt Intrauterine Contraceptive Devices Market By Product 2025-2033 (USD Million)

By Product	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Mirena	XX.x	XX.x	XX.x	7.47	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Skyla	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Paragard	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Essure	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Levosert	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Egypt Intrauterine Contraceptive Devices Market By End-User 2025-2033 (USD Million)

By End-User	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Hospitals	XX.x	XX.x	XX.x	11.2	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Gynecology Clinics	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Community Healthcare Centers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.